SAP (NYSE:SAP – Get Free Report) and OptimizeRx (NASDAQ:OPRX – Get Free Report) are both computer and technology companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, earnings, analyst recommendations, institutional ownership, valuation, dividends and profitability.
Volatility & Risk
SAP has a beta of 1.28, meaning that its stock price is 28% more volatile than the S&P 500. Comparatively, OptimizeRx has a beta of 1.25, meaning that its stock price is 25% more volatile than the S&P 500.
Earnings & Valuation
This table compares SAP and OptimizeRx”s top-line revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| SAP | $36.99 billion | 8.98 | $3.38 billion | $6.04 | 44.78 |
| OptimizeRx | $92.13 million | 3.78 | -$18.66 million | ($0.54) | -34.72 |
SAP has higher revenue and earnings than OptimizeRx. OptimizeRx is trading at a lower price-to-earnings ratio than SAP, indicating that it is currently the more affordable of the two stocks.
Analyst Ratings
This is a summary of current ratings and price targets for SAP and OptimizeRx, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| SAP | 0 | 1 | 13 | 1 | 3.00 |
| OptimizeRx | 1 | 3 | 8 | 1 | 2.69 |
SAP presently has a consensus target price of $281.67, indicating a potential upside of 4.14%. OptimizeRx has a consensus target price of $11.81, indicating a potential downside of 37.00%. Given SAP’s stronger consensus rating and higher probable upside, analysts clearly believe SAP is more favorable than OptimizeRx.
Profitability
This table compares SAP and OptimizeRx’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| SAP | 18.26% | 14.84% | 9.01% |
| OptimizeRx | -9.42% | 4.50% | 3.12% |
Insider and Institutional Ownership
76.5% of OptimizeRx shares are owned by institutional investors. 7.4% of SAP shares are owned by insiders. Comparatively, 5.6% of OptimizeRx shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
Summary
SAP beats OptimizeRx on 13 of the 14 factors compared between the two stocks.
About SAP
SAP SE, together with its subsidiaries, provides applications, technology, and services worldwide. It offers SAP S/4HANA that provides software capabilities for finance, risk and project management, procurement, manufacturing, supply chain and asset management, and research and development; SAP SuccessFactors solutions for human resources, including HR and payroll, talent and employee experience management, and people and workforce analytics; and spend management solutions that covers direct and indirect spend, travel and expense, and external workforce management. The company also provides SAP customer experience solutions; SAP Business Technology platform that enables customers and partners to build, integrate, and automate applications; and SAP Business Network, a business-to-business collaboration platform that helps digitalize key business processes across the supply chain and enables communication between trading partners. In addition, it offers SAP Signavio to help customers to discover, analyze, and understand their business process operations; SAP's industry cloud solutions that provides modular solutions addressing industry-specific functions; Taulia solutions for working capital management to help enable customers mitigate the effects of inflation by providing visibility into working capital and access to liquidity; and sustainability solutions and services. SAP SE was founded in 1972 and is headquartered in Walldorf, Germany.
About OptimizeRx
OptimizeRx Corporation, a digital health technology company, enables care-focused engagement between life sciences organizations, healthcare providers, and patients at critical junctures throughout the patient care journey. It offers various tech-enabled marketing solutions through its Artificial Intelligence-generated Dynamic Audience and Activation Platform, which enables customers to execute traditional marketing campaigns on its proprietary digital point-of-care network, as well as dynamic marketing campaigns that optimize audiences in real time to increase the value of treatment information for healthcare professionals and patients in response to clinical care events. The company was founded in 2006 and is based in Waltham, Massachusetts.
Receive News & Ratings for SAP Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SAP and related companies with MarketBeat.com's FREE daily email newsletter.
